Merck & Co.

Empresa farmacêutica multinacional americana

0membros1here now

Pergunte ao Genius Site

Merck & Co.· Finance · 5 sources · Aug 19, 2026Story

Wall Street rises as yields ease, Moderna lifts healthcare stocks

U.S. stocks rose modestly as easing government yields supported risk appetite, with Moderna’s strong rally boosting the healthcare sector and lifting major indexes. Investors weighed Fed minutes signaling potential rate hikes against Treasury moves to expand liquidity supports, keeping a wary view on longer-term rate trajectories for tech and other high-flyers.

Finance· Aug 19, 2026

0

Merck & Co.· Health · 543 sources · Aug 19, 2026Story

Melanoma Trial Shows Positive Personalized mRNA Vaccine

Merck and Moderna reported positive Phase 3 results for their personalized mRNA cancer vaccine intismeran autogene (V940/mRNA-4157) added to Keytruda in high-risk, surgically treated melanoma, showing longer recurrence-free survival and reduced distant metastasis with no new safety issues. The companies plan regulatory discussions and potential accelerated approval submissions, with data presentations at upcoming medical meetings and continued follow-up for overall survival.

Health· Aug 19, 2026

0

Merck & Co.

Empresa farmacêutica multinacional americana

0membros1here now

Pergunte ao Genius Site

Merck & Co.· Finance · 5 sources · Aug 19, 2026Story

Wall Street rises as yields ease, Moderna lifts healthcare stocks

U.S. stocks rose modestly as easing government yields supported risk appetite, with Moderna’s strong rally boosting the healthcare sector and lifting major indexes. Investors weighed Fed minutes signaling potential rate hikes against Treasury moves to expand liquidity supports, keeping a wary view on longer-term rate trajectories for tech and other high-flyers.

Finance· Aug 19, 2026

0

Merck & Co.· Health · 543 sources · Aug 19, 2026Story

Melanoma Trial Shows Positive Personalized mRNA Vaccine

Merck and Moderna reported positive Phase 3 results for their personalized mRNA cancer vaccine intismeran autogene (V940/mRNA-4157) added to Keytruda in high-risk, surgically treated melanoma, showing longer recurrence-free survival and reduced distant metastasis with no new safety issues. The companies plan regulatory discussions and potential accelerated approval submissions, with data presentations at upcoming medical meetings and continued follow-up for overall survival.

Health· Aug 19, 2026

0

Merck & Co. across IJR

Ask Genius by OpenServe about Merck & Co.Create in Studio Build a game Watch videos

Merck & Co. across IJR

Ask Genius by OpenServe about Merck & Co.Create in Studio Build a game Watch videos

Últimas notícias e discussão sobre Merck & Co.

Wall Street rises as yields ease, Moderna lifts healthcare stocks

Melanoma Trial Shows Positive Personalized mRNA Vaccine

Últimas notícias e discussão sobre Merck & Co.

Wall Street rises as yields ease, Moderna lifts healthcare stocks

Melanoma Trial Shows Positive Personalized mRNA Vaccine

Merck & Co. across IJR

Merck & Co. across IJR